LRP-1 Silencing Prevents Malignant Cell Invasion despite Increased Pericellular Proteolytic Activities

REFERENCES

• Andreasen, P. A., R. Egelund, and H. H. Petersen. 2000. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol. Life Sci. 57:25–40.
   PubMed Web of Science ®Google Scholar
• Barmina, O. Y., H. W. Walling, G. J. Fiacco, J. M. Freije, C. Lopez-Otin, J. J. Jeffrey, and N. C. Partridge. 1999. Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J. Biol. Chem. 274:30087–30093.
   PubMed Web of Science ®Google Scholar
• Boucher, P., M. Gotthardt, W. P. Li, R. G. Anderson, and J. Herz. 2003. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300:329–332.
   PubMed Web of Science ®Google Scholar
• Bu, G., P. A. Morton, and A. L. Schwartz. 1992. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor. J. Biol. Chem. 267:15595–15602.
   PubMedGoogle Scholar
• Chazaud, B., S. Bonavaud, A. Plonquet, M. Pouchelet, R. K. Gherardi, and G. Barlovatz-Meimon. 2000. Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility. Exp. Cell Res. 258:237–244.
   PubMedGoogle Scholar
• Chazaud, B., R. Ricoux, C. Christov, A. Plonquet, R. K. Gherardi, and G. Barlovatz-Meimon. 2002. Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. Am. J. Pathol. 160:237–246.
   PubMed Web of Science ®Google Scholar
• Conese, M., A. Nykjaer, C. M. Petersen, O. Cremona, R. Pardi, P. A. Andreasen, J. Gliemann, E. I. Christensen, and F. Blasi. 1995. Alpha-2 macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor. J. Cell Biol. 131:1609–1622.
   PubMed Web of Science ®Google Scholar
• Croucher, D., D. N. Saunders, and M. Ranson. 2006. The urokinase/PAI-2 complex: a new high affinity ligand for the endocytosis receptor low density lipoprotein receptor-related protein. J. Biol. Chem. 281:10206–10213.
   PubMedGoogle Scholar
• Czekay, R. P., T. A. Kuemmel, R. A. Orlando, and M. G. Farquhar. 2001. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Mol. Biol. Cell 12:1467–1479.
   PubMed Web of Science ®Google Scholar
• Dedieu, S., and P. Lefebvre. 2006. Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. Cell. Signal. 18:889–898.
   PubMed Web of Science ®Google Scholar
• Dedieu, S., S. Poussard, G. Mazeres, F. Grise, E. Dargelos, P. Cottin, and J. J. Brustis. 2004. Myoblast migration is regulated by calpain through its involvement in cell attachment and cytoskeletal organization. Exp. Cell Res. 292:187–200.
   PubMed Web of Science ®Google Scholar
• Degryse, B., J. G. Neels, R. P. Czekay, K. Aertgeerts, Y. Kamikubo, and D. J. Loskutoff. 2004. The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. J. Biol. Chem. 279:22595–22604.
   PubMed Web of Science ®Google Scholar
• Deryugina, E. I., G. X. Luo, R. A. Reisfeld, M. A. Bourdon, and A. Strongin. 1997. Tumor cell invasion through Matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res. 17:3201–3210.
   PubMed Web of Science ®Google Scholar
• Desrosiers, R. R., M. E. Rivard, P. E. Grundy, and B. Annabi. 2006. Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors. Pediatr. Blood Cancer 46:40–49.
   PubMed Web of Science ®Google Scholar
• Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2:161–174.
   PubMed Web of Science ®Google Scholar
• Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498.
   PubMed Web of Science ®Google Scholar
• Ellis, V., M. F. Scully, and V. V. Kakkar. 1989. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J. Biol. Chem. 264:2185–2188.
   PubMed Web of Science ®Google Scholar
• Emonard, H., G. Bellon, P. de Diesbach, M. Mettlen, W. Hornebeck, and P. J. Courtoy. 2005. Regulation of matrix metalloproteinase (MMP) activity by the low-density lipoprotein receptor-related protein (LRP). A new function for an “old friend”. Biochimie 87:369–376.
   PubMed Web of Science ®Google Scholar
• Emonard, H., G. Bellon, L. Troeberg, A. Berton, A. Robinet, P. Henriet, E. Marbaix, K. Kirkegaard, L. Patthy, Y. Eeckhout, H. Nagase, W. Hornebeck, and P. J. Courtoy. 2004. Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2. TIMP-2 complex through a thrombospondin-independent mechanism. J. Biol. Chem. 279:54944–54951.
   PubMed Web of Science ®Google Scholar
• Foca, C., E. K. Moses, M. A. Quinn, and G. E. Rice. 2000. Differential expression of the alpha(2)-macroglobulin receptor and the receptor associated protein in normal human endometrium and endometrial carcinoma. Mol. Hum. Reprod. 6:921–927.
   PubMed Web of Science ®Google Scholar
• Giannone, G., G. Jiang, D. H. Sutton, D. R. Critchley, and M. P. Sheetz. 2003. Talin1 is critical for force-dependent reinforcement of initial integrin-cytoskeleton bonds but not tyrosine kinase activation. J. Cell Biol. 163:409–419.
   PubMed Web of Science ®Google Scholar
• Goretzki, P. E., A. Frilling, D. Simon, and H. D. Roeher. 1990. Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res. 118:48–63.
   PubMedGoogle Scholar
• Goto, M., and K. Mizunashi. 1999. Calcitonin stimulates lysosomal enzyme release and uptake in LLC-PK1 cells. J. Am. Soc. Nephrol. 10:1640–1648.
   PubMedGoogle Scholar
• Hahn-Dantona, E., J. F. Ruiz, P. Bornstein, and D. K. Strickland. 2001. The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J. Biol. Chem. 276:15498–15503.
   PubMed Web of Science ®Google Scholar
• Herz, J., and D. K. Strickland. 2001. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Investig. 108:779–784.
   PubMed Web of Science ®Google Scholar
• Hornebeck, W., H. Emonard, J. C. Monboisse, and G. Bellon. 2002. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin. Cancer Biol. 12:231–241.
   PubMed Web of Science ®Google Scholar
• Kancha, R. K., M. E. Stearns, and M. M. Hussain. 1994. Decreased expression of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells. Oncol. Res. 6:365–372.
   PubMed Web of Science ®Google Scholar
• Kim, S. J., J. W. Park, J. S. Yoon, J. O. Mok, Y. J. Kim, H. K. Park, C. H. Kim, D. W. Byun, Y. J. Lee, S. Y. Jin, K. I. Suh, and M. H. Yoo. 2004. Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study. J. Korean Med. Sci. 19:710–715.
   PubMedGoogle Scholar
• Laufs, S., J. Schumacher, and H. Allgayer. 2006. Urokinase-receptor (u-PAR): an essential player in multiple games of cancer: a review on its role in tumor progression, invasion, metastasis, proliferation/dormancy, clinical outcome and minimal residual disease. Cell. Cycle 5:1760–1771.
   PubMed Web of Science ®Google Scholar
• Li, Y., W. Lu, and G. Bu. 2003. Essential role of the low density lipoprotein receptor-related protein in vascular smooth muscle cell migration. FEBS Lett. 555:346–350.
   PubMed Web of Science ®Google Scholar
• Li, Y., N. Wood, P. Grimsley, D. Yellowlees, and P. K. Donnelly. 1998. In vitro invasiveness of human breast cancer cells is promoted by low density lipoprotein receptor-related protein. Invasion Metastasis 18:240–251.
   PubMedGoogle Scholar
• Ma, Z., K. S. Thomas, D. J. Webb, R. Moravec, A. M. Salicioni, W. M. Mars, and S. L. Gonias. 2002. Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. J. Cell Biol. 159:1061–1070.
   PubMed Web of Science ®Google Scholar
• Michaud-Levesque, J., Y. Rolland, M. Demeule, Y. Bertrand, and R. Beliveau. 2005. Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic system. Biochim. Biophys. Acta 1743:243–253.
   PubMedGoogle Scholar
• Miller, D. M., Y. Zhang, B. M. Rahill, W. J. Waldman, and D. D. Sedmak. 1999. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J. Immunol. 162:6107–6113.
   PubMed Web of Science ®Google Scholar
• Monea, S., K. Lehti, J. Keski-Oja, and P. Mignatti. 2002. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. J. Cell Physiol. 192:160–170.
   PubMed Web of Science ®Google Scholar
• Montel, V., A. Gaultier, R. D. Lester, W. M. Campana, and S. L. Gonias. 2007. The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development. Cancer Res. 67:9817–9824.
   PubMed Web of Science ®Google Scholar
• Morrison, C. J., G. S. Butler, H. F. Bigg, C. R. Roberts, P. D. Soloway, and C. M. Overall. 2001. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J. Biol. Chem. 276:47402–47410.
   PubMed Web of Science ®Google Scholar
• Myohanen, H., and A. Vaheri. 2004. Regulation and interactions in the activation of cell-associated plasminogen. Cell. Mol. Life Sci. 61:2840–2858.
   PubMed Web of Science ®Google Scholar
• Neuhaus, P., B. Jaschinsky, S. Schneider, H. Neuhaus, A. Wolter, H. Ebelt, and T. Braun. 2006. Overexpression of Kelch domain containing-2 (mKlhdc2) inhibits differentiation and directed migration of C2C12 myoblasts. Exp. Cell Res. 312:3049–3059.
   PubMedGoogle Scholar
• Nykjaer, A., M. Conese, E. I. Christensen, D. Olson, O. Cremona, J. Gliemann, and F. Blasi. 1997. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J. 16:2610–2620.
   PubMed Web of Science ®Google Scholar
• Okada, S. S., S. R. Grobmyer, and E. S. Barnathan. 1996. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion. Arterioscler. Thromb. Vasc. Biol. 16:1269–1276.
   PubMed Web of Science ®Google Scholar
• Orr, A. W., M. A. Pallero, and J. E. Murphy-Ullrich. 2002. Thrombospondin stimulates focal adhesion disassembly through Gi- and phosphoinositide 3-kinase-dependent ERK activation. J. Biol. Chem. 277:20453–20460.
   PubMedGoogle Scholar
• Orr, A. W., C. E. Pedraza, M. A. Pallero, C. A. Elzie, S. Goicoechea, D. K. Strickland, and J. E. Murphy-Ullrich. 2003. Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly. J. Cell Biol. 161:1179–1189.
   PubMed Web of Science ®Google Scholar
• Rothhut, B., C. Ghoneim, F. Antonicelli, and M. Soula-Rothhut. 2007. Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through focal adhesion kinase. Biochimie 89:613–624.
   PubMed Web of Science ®Google Scholar
• Salicioni, A. M., A. Gaultier, C. Brownlee, M. K. Cheezum, and S. L. Gonias. 2004. Low density lipoprotein receptor-related protein-1 promotes beta1 integrin maturation and transport to the cell surface. J. Biol. Chem. 279:10005–10012.
   PubMed Web of Science ®Google Scholar
• Sid, B., S. Dedieu, N. Delorme, H. Sartelet, G. M. Rath, G. Bellon, and L. Martiny. 2006. Human thyroid carcinoma cell invasion is controlled by the low density lipoprotein receptor-related protein-mediated clearance of urokinase plasminogen activator. Int. J. Biochem. Cell. Biol. 38:1729–1740.
   PubMed Web of Science ®Google Scholar
• Sidenius, N., and F. Blasi. 2003. The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev. 22:205–222.
   PubMed Web of Science ®Google Scholar
• Smit, J. W., G. van der Pluijm, H. A. Romijn, C. W. Lowik, H. Morreau, and B. M. Goslings. 1999. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system. Thyroid 9:913–919.
   PubMedGoogle Scholar
• Spijkers, P. P., P. da Costa Martins, E. Westein, C. G. Gahmberg, J. J. Zwaginga, and P. J. Lenting. 2005. LDL-receptor-related protein regulates beta2-integrin-mediated leukocyte adhesion. Blood 105:170–177.
   PubMed Web of Science ®Google Scholar
• Strat, A., L. Gao, T. Utsuki, B. Cheng, S. Nuthalapaty, J. M. Mathis, Y. Odaka, and T. Giordano. 2006. Specific and nontoxic silencing in mammalian cells with expressed long dsRNAs. Nucleic Acids Res. 34:3803–3810.
   PubMedGoogle Scholar
• Strickland, D. K., J. D. Ashcom, S. Williams, W. H. Burgess, M. Migliorini, and W. S. Argraves. 1990. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265:17401–17404.
   PubMed Web of Science ®Google Scholar
• Strickland, D. K., and S. Ranganathan. 2003. Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J. Thromb. Haemost. 1:1663–1670.
   PubMedGoogle Scholar
• Sun, W. H., C. Pabon, Y. Alsayed, P. P. Huang, S. Jandeska, S. Uddin, L. C. Platanias, and S. T. Rosen. 1998. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood 91:570–576.
   PubMed Web of Science ®Google Scholar
• Swertfeger, D. K., G. Bu, and D. Y. Hui. 2002. Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration. J. Biol. Chem. 277:4141–4146.
   PubMedGoogle Scholar
• Takayama, Y., P. May, R. G. Anderson, and J. Herz. 2005. Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta). J. Biol. Chem. 280:18504–18510.
   PubMed Web of Science ®Google Scholar
• Turner, C. E. 2000. Paxillin and focal adhesion signalling. Nat. Cell Biol. 2:E231–E236.
   PubMed Web of Science ®Google Scholar
• Weaver, A. M., I. M. Hussaini, A. Mazar, J. Henkin, and S. L. Gonias. 1997. Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J. Biol. Chem. 272:14372–14379.
   PubMedGoogle Scholar
• Webb, D. J., D. H. Nguyen, and S. L. Gonias. 2000. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and Matrigel invasion. J. Cell Sci. 113:123–134.
   PubMed Web of Science ®Google Scholar
• Wen, L. P., J. A. Fahrni, S. Troie, J. L. Guan, K. Orth, and G. D. Rosen. 1997. Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem. 272:26056–26061.
   PubMed Web of Science ®Google Scholar
• Westhoff, M. A., B. Serrels, V. J. Fincham, M. C. Frame, and N. O. Carragher. 2004. SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Mol. Cell. Biol. 24:8113–8133.
   PubMed Web of Science ®Google Scholar
• Wijnberg, M. J., P. H. Quax, N. M. Nieuwenbroek, and J. H. Verheijen. 1997. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein. Thromb. Haemost. 78:880–886.
   PubMedGoogle Scholar
• Yang, Z., D. K. Strickland, and P. Bornstein. 2001. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J. Biol. Chem. 276:8403–8408.
   PubMed Web of Science ®Google Scholar
• Zaman, M. H., L. M. Trapani, A. L. Sieminski, D. Mackellar, H. Gong, R. D. Kamm, A. Wells, D. A. Lauffenburger, and P. Matsudaira. 2006. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc. Natl. Acad. Sci. USA 103:10889–10894.
   PubMed Web of Science ®Google Scholar
• Zhuo, M., D. M. Holtzman, Y. Li, H. Osaka, J. DeMaro, M. Jacquin, and G. Bu. 2000. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J. Neurosci. 20:542–549.
   PubMedGoogle Scholar